SCHEMBL21153262

SCHEMBL21153262

CN(C)c1ccc(/N=N/c2ccc(C(=O)NCCc3cc(F)c(OCC(=O)[C@H](CCCCN)NC(=O)c4cccc(N)c4)c(F)c3)cc2)cc1

nearest known ligand 0.84

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
PRSS1 P07477 2/20 0.41
PRSS2 P07478 2/20 0.41
PRSS3 P35030 2/20 0.41
TPSAB1 Q15661 2/20 0.41
CTSH P09668 1/20 0.41
CTSK P43235 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21153253 1.00 PRSS1 (0.41) PRSS1PRSS2PRSS3TPSAB1CTSH
SCHEMBL21153255 0.93 CTSK (0.41) CTSHCTSK
SCHEMBL21153247 0.93 CTSK (0.41) CTSHCTSK
SCHEMBL19982971 0.91 PRSS1 (0.39) PRSS1PRSS2PRSS3TPSAB1
SCHEMBL19983033 0.91 PRSS1 (0.39) PRSS1PRSS2PRSS3TPSAB1
SCHEMBL19982922 0.84 CTSK (0.39) CTSHCTSK
SCHEMBL19982920 0.84 CTSK (0.39) CTSHCTSK
SCHEMBL21113155 0.84 CTSK (0.39) CTSHCTSK
SCHEMBL19972786 0.84 CTSK (0.39) CTSHCTSK
SCHEMBL25658966 0.83 TDP1 (0.39) PRSS1PRSS2PRSS3TPSAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142714-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2023-05-11 US disclosed
US-11325884-B2 Ketone inhibitors of lysine gingipain Cortexyme, Inc. (US) 2022-05-10 US disclosed
US-20210053908-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2021-02-25 US disclosed
US-10730826-B2 Ketone inhibitors of lysine gingipain Cortexyme, Inc. (US) 2020-08-04 US disclosed
US-20190210960-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN Cortexyme, Inc. (US) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210053908-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN PHYKPL, ENPEP, PREP PRSS1 140/4885PRSS2 389/4885PRSS3 339/4885
US-20230142714-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN PHYKPL, ENPEP, PREP PRSS1 140/4885PRSS2 389/4885PRSS3 339/4885
US-10730826-B2 Ketone inhibitors of lysine gingipain PHYKPL, ENPEP, PREP PRSS1 140/4885PRSS2 389/4885PRSS3 339/4885
US-20190210960-A1 KETONE INHIBITORS OF LYSINE GINGIPAIN PHYKPL, ENPEP, PREP PRSS1 140/4885PRSS2 389/4885PRSS3 339/4885
US-11325884-B2 Ketone inhibitors of lysine gingipain PHYKPL, ENPEP, PREP PRSS1 140/4885PRSS2 389/4885PRSS3 339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.